[Combined therapy for unresectable hepatocellular carcinoma with hepatic arterial infusion of lymphokine-activated killer cells from autologous splenocytes and of lipiodolized antitumor agent].
Chuganji
Y
Y
Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki.
Matsuzaki
Y
Y
Ebihara
T
T
Shoda
J
J
Nishi
M
M
Matsumoto
H
H
Tanaka
N
N
Koyama
S
S
Fukutomi
H
H
Osuga
T
T
D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D006499:Hepatic Artery; D006801:Humans; D007116:Immunization, Passive; D007261:Infusions, Intra-Arterial; D007459:Iodized Oil / Q000008:administration & dosage*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D008113:Liver Neoplasms / Q000628:therapy*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage*; D013154:Spleen / Q000166:cytology
D008937:Mitomycins; D016685:Mitomycin; D007459:Iodized Oil